An Open-Label Study of Diazoxide Choline in Patients With Genetic Obesities

Clinical trial NCT05532020 · UNKNOWN

Trial details

NCT number: NCT05532020
Sponsor: Soleno Therapeutics, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

SH2B1 Deficiency Obesity Obesity Associated With PCSK1 Mutation (rs6232 Variant)SIM1 Deficiency Obesity

Start date: 2023-01-01
Primary completion: 2024-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.